Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02713217
Other study ID # CRE 12-310
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 25, 2017
Est. completion date March 31, 2021

Study information

Verified date January 2021
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Integrating mental health treatments into the primary care delivered at Community Based Outpatient Clinics(CBOCs) that are geographically accessible to rural Veterans is a major priority for the Department of Veterans Affairs. However, there is no scientific evidence that integrating mental health and primary care is clinically effective at smaller CBOCs that have limited mental health staffing. The goal of this proposed project is to implement a "blended" combination of integrated care models that have been adapted for smaller CBOCs using telemedicine technologies, and evaluate the acceptability and effectiveness of the blended, telemedicine-based, integrated care model. If clinical outcomes are improved compared to usual care, findings will be used to justify and facilitate the implementation of this telemedicine-based integrated care model at smaller CBOCs in order to increase rural Veterans' access to effective mental health treatments.


Description:

Background: Providing mental health care to rural Veterans in geographically accessible Community Based Outpatient Clinics (CBOCs) is a major priority of the Office of Rural Health. Likewise, integrating mental health into primary care is one of the highest priorities of the Office of Mental Health Services and the Office of Mental Health Operations. The Uniform Mental Health Services Handbook mandates the blending of the two predominant, evidence-based models of integrated care (the Care Management model and the Co-Located model) at VAMCs, very large CBOCs, and large CBOCs. Because there is no scientific evidence to support its implementation, the "Blended model" is not mandated at medium CBOCs or small CBOCs that serve rural Veterans. At most smaller CBOCs, on-site mid-level providers and/or off-site tele-psychiatrists and tele-psychologists deliver traditional referral-based specialty treatment (Referral model) rather than integrated care. Objective: This project contributes to Specific Aim 3 (Test clinical interventions to improve quality and outcomes of mental health care at CBOCs) of the Little Rock CREATE application. The goal of this proposed Hybrid Type 2 pragmatic effectiveness-implementation trial is to generate the scientific evidence needed to justify the national dissemination of the Blended model adapted using telemedicine technologies to accommodate the clinical context of smaller CBOCs that lack on-site psychiatrists and PhD psychologists. The resulting Telemedicine Blended model will be compared to usual care (Referral model) in a pragmatic trial, where the intervention will be delivered via interactive video by centrally located clinical staff and fidelity will be monitored but not controlled. Specific Aim 1: Use an expert panel comprised of clinical providers and managers who are applying telemedicine to provide a Blended model for CBOCs lacking on-site PhD psychologists and psychiatrists to document the core components of a Telemedicine Blended model and using a PDSA process, implement this model in six CBOCs. Specific Aim 2: Conduct a Hybrid Type 2 pragmatic effectiveness-implementation trial of the adapted Telemedicine Blended model by assessing RE-AIM outcomes including: provider Reach into the patient population, Effectiveness at improving clinical outcomes, Adoption by providers and Implementation Fidelity. Methods: In conjunction with national, regional and local partners, including providers and managers who have experience with the Telemedicine Blended model, the Blended model will be adapted for smaller CBOCs using telemedicine technologies and pilot tested to generate a standardized treatment protocol. We will use a stepped wedge design with randomization of sites to sequential implementation steps, and CBOC patients who screen positive for depression or alcohol disorders will be recruited and consented to participate in the Hybrid Type 2 pragmatic effectiveness-implementation trial. Data about Reach and Adoption will be obtained from the Corporate Data Warehouse. Data about Implementation Fidelity will be obtained from chart review. Data about clinical Effectiveness will be obtained from telephone survey. Impact: If the Telemedicine Blended model improves clinical outcomes compared to usual care, results will be used to justify and facilitate the implementation of the Telemedicine Blended model at smaller CBOCs.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 588
Est. completion date March 31, 2021
Est. primary completion date July 24, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The investigators will enroll Veterans who screen positive on routinely administered VA mental health screens for depressive disorders, alcohol use disorders, and PTSD at the 6 study CBOCs. Exclusion Criteria: - Patients receiving specialty mental health treatment in the 6 months prior to recruitment and those who have a diagnosis of PTSD - Those with a diagnosis of substance dependence - Those with a psychotic disorder diagnosis: - schizophrenia - bipolar disorder - other psychotic disorders

Study Design


Intervention

Other:
Usual Care
This condition is defined as usual care occurring within Community Based Outpatient Clinics (CBOCs), which typically does not involve substantial integration of mental health care and primary care.
Blended Telemedicine-Based Integrated Care
This condition involves exposure to a blended collaborative care model that includes care management for depression and alcohol disorders and "virtual co-location" of doctoral-level mental health providers with prompt access through tele-video or telephone communication.

Locations

Country Name City State
United States Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR North Little Rock Arkansas

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

References & Publications (2)

Bauer MS, Miller C, Kim B, Lew R, Weaver K, Coldwell C, Henderson K, Holmes S, Seibert MN, Stolzmann K, Elwy AR, Kirchner J. Partnering with health system operations leadership to develop a controlled implementation trial. Implement Sci. 2016 Feb 24;11:22 — View Citation

Owen RR, Woodward EN, Drummond KL, Deen TL, Oliver KA, Petersen NJ, Meit SS, Fortney JC, Kirchner JE. Using implementation facilitation to implement primary care mental health integration via clinical video telehealth in rural clinics: protocol for a hybr — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Adoption of intervention by primary care providers Proportion of primary care providers with at least one patient with a Primary Care-Mental Health Integration encounter following implementation of the blended, integrated care model. The time frame is variable due to the stepped wedge design. 12-24 months
Other Reach of intervention Proportion of patients having any mental health encounter in the six month follow-up period. Six months
Primary Change in SF-12V Mental Health Composite Scale scores Change in overall mental health functioning from study enrollment (after screening positive for depressive disorder or alcohol use disorder) to six-month follow-up. Six months
Secondary Change in PHQ-9 scores Change in depressive symptoms as measured by PHQ-9 from study enrollment to six-month follow-up, for patients screening positive for depressive disorders at baseline. Six months
Secondary Change in AUDIT-C scores Change in alcohol use symptoms from study enrollment to six-month follow-up, for patients screening positive for alcohol use disorders at baseline. Six months
See also
  Status Clinical Trial Phase
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02113618 - Effect of Cognitive Training on Alcohol Use Outcomes N/A
Completed NCT01008280 - Baclofen to Reduce Alcohol Use in Veterans With HCV Phase 4
Active, not recruiting NCT02671019 - Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care N/A
Completed NCT01751035 - Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD N/A
Active, not recruiting NCT03695653 - Messaging Interventions to Reduce Alcohol Problems Project N/A
Completed NCT02298751 - Exposure Therapy as Aftercare for Alcohol Use Disorder N/A
Terminated NCT01566370 - Zonisamide for Heavy Drinkers With Bipolar Disorder Phase 2
Completed NCT01642381 - Component Analysis for Motivational Interviewing N/A
Completed NCT02384278 - Internet Based Cognitive Behavior Treatment for Alcohol Problems N/A
Completed NCT02511808 - Adaptive Interventions for Problem Drinkers N/A
Completed NCT01613014 - ABT-436 for Alcohol Dependence Phase 2
Completed NCT02905162 - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
Completed NCT02808468 - Brief Restructuring Intervention Following Trauma Exposure N/A
Completed NCT01692054 - Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication N/A
Completed NCT02500602 - CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders Phase 2
Recruiting NCT02465177 - Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
Completed NCT02193256 - Varenicline + Prazosin for Heavy Drinking Smokers Early Phase 1
Completed NCT01172210 - Examining Common Substrates of Eating and Alcohol Use Disorders N/A
Completed NCT02885311 - Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home Phase 1/Phase 2